Xtx Topco LTD Bristol Myers Squibb CO Transaction History

Xtx Topco LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $2.95 Million - $3.88 Million	73,183 Added 400.3%	91,465 $3.8 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $556,663 - $631,148	11,602 Added 173.68%	18,282 $991,000
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $323,846 - $386,438	6,680 New	6,680 $342,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $887,416 - $985,337	13,929 New	13,929 $890,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $1.63 Million - $1.92 Million	23,730 New	23,730 $1.71 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $298,546 - $357,984	-4,856 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $388,924 - $453,395	-7,252 Reduced 59.89%	4,856 $303,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $370,404 - $433,880	6,260 Added 107.05%	12,108 $716,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $18,325 - $19,956	-296 Reduced 4.82%	5,848 $391,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $364,584 - $410,050	6,144 New	6,144 $388,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.